I’ve seen more IPOs than I’ve seen clean exits.
And let me tell you: most people look at an IPO as a finish line. A celebration. A payout.
They’re wrong. Dead wrong.
An IPO is a stress test. It’s a pressure cooker designed to reveal every crack in a company’s foundation. The market doesn’t reward you for showing up. It punishes you for what you’re hiding.
And when I read that AlgoSec is weighing a London Stock Exchange listing, I don’t see a happy story. I see a series of questions. I see a trade setup. I see a structure that needs to be broken down, line by line, before any sane trader touches it.
This isn’t a feel-good piece about European cyber champions. This is a dissection. A post-mortem of a thesis before it even executes.
Let me be blunt: cybersecurity is a brutal sector. Margins are squeezed by giants like Palo Alto and CrowdStrike. Switching costs are high — that’s the only real moat. But AlgoSec? They’re betting on Europe. On London. On a capital market that’s historically been second-tier for tech.
That’s a bold move. And I’m here to test it.
Here’s the architecture of my analysis, the same framework I use to audit any potential position:
Hook: The Price Action That Isn’t There Yet
When news breaks about a company considering an IPO, don’t look at the stock price. Look at the whisper market. Look at the private secondary trades. Look at the implied volatility.
For AlgoSec, the whisper is muted. That’s a red flag. A strong IPO candidate generates noise — employees selling, VCs hedging, bankers lining up. Silence means uncertainty. It means the market is waiting for data, not buying a story.
I’ve been in this game long enough to know that silence is the most expensive noise.
Context: The Battlefield
AlgoSec isn’t a startup. It’s a mature cybersecurity SaaS platform, focused on network security policy management. They’re not a consumer play. They’re enterprise. They’re sticky. They have high switching costs — a classic SaaS moat.
But here’s the thing: cybersecurity is currently the hottest arena for public markets. Every major player is eyeing Europe. The EU’s NIS2 directive is forcing compliance spending. Governments are scared. Companies are desperate.
That’s the context. A sector flooded with demand, but also flooded with competition. AlgoSec is trying to position itself as the European champion, not the global one. That’s a smart narrative, but it’s also a narrow one.
Core: Reading the LOB (Limit Order Book) of Capital
Every IPO is an order book. But here, the book is the market itself. I look at three layers:
- Liquidity: LSE isn’t NASDAQ. It has lower liquidity for tech names. That means lower valuation multiples. AlgoSec is trading a potentially higher valuation for a more stable, but less liquid home. For a trader, that’s a warning: if you want to exit, you’ll pay a spread.
- Volatility: The cybersecurity space is volatile. Government contracts, zero-day exploits, tech shifts. AlgoSec’s revenue is likely predictable, but the sector’s sentiment is not. The IPO will be priced at a discount to account for that. If you’re buying in the open market, you’re paying for the uncertainty premium.
- Order Flow: Who’s selling? If the VCs and founders are offloading significant shares in the IPO, that’s a red flag. If they’re retaining, it’s a signal of conviction. Watch the lock-up periods. Watch the insider sales. That’s the real order flow, not the retail noise.
I’ve shorted more than one hyped IPO. The pattern is always the same: push the price up on day one, let the institutions unload to retail, then let the price drift down. It’s not malice — it’s mathematics.
Contrarian: The Trap of ‘Home Advantage’
The market narrative is that AlgoSec is smart to list in London because they’re “European” and “close to their customers”.
I call that fluff.
The real reason is likely simpler: they didn’t get the valuation they wanted from NASDAQ. The US market is ruthless for non-US companies. They ask for growth at any cost. AlgoSec is mature. Their growth is likely slower, but their margins are healthier.
That’s a good business. But it’s not a sexy IPO.
London will give them a multiple that’s 20-30% lower than NASDAQ. In exchange, they get less scrutiny and a more patient investor base. That’s a trade-off. A rational one. But don’t mistake it for a victory.
Takeaway: The Trade, Not the Story
If AlgoSec IPOs at a fair valuation (say, 5-6x forward revenue, which is typical for mature SaaS), I’d be cautious buying on day one. Wait for the lock-up expiry. Let the insider selling happen. Let the stock find its natural level.
If the price drops 20% after the quiet period ends, that’s your entry. Not before.
The market doesn’t reward patience with higher prices. It rewards patience with better entries.
Remember: every IPO is a test. And the test doesn’t end on the first trade. It ends when the smart money stops selling.
Don’t follow the herd. Lead your bot.
So here’s my bottom line: AlgoSec is a solid company in a hot space. But the IPO is not a buy signal. It’s a data point. Wait for the data. Let the market do its dirty work.
And when the fear is real? That’s when you step in.
The tighter the spread, the wider the greed.
That’s not just a trading maxim. It’s a fact of life in capital markets. And this IPO? It’s a trade that demands more patience than enthusiasm.
Now, someone’s going to read this and call me a contrarian cynic.
They’re not wrong. But they’re also not profitable.